6 things you need to know about Bladder Cancer | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Bladder cancer

June 2018

6 things you need to know about Bladder Cancer

  • Bladder cancer is the ninth most commonly diagnosed cancer in the world with an estimated 430 000 new cases reported in 2012.
  • Men are more than three times more likely to get bladder cancer than women.
  • Smoking is a major cause of bladder cancer.
  • Exposure to industrial chemicals such as metalworking fluids is another cause of bladder cancer.
  • One of the most common symptoms of bladder cancer is the presence of blood in urine.
  • Cystoscopy and urine cytology are the most common methods for detection and assessment of recurrence of bladder cancer. Cystoscopy may cause pain and discomfort in patients, and urine cytology has a low sensitivity.IDL Biotech has developed UBC Rapid, a complement to cystoscopy, which causes no pain for the patient. Read more about UBC Rapid here.

IDL Biotech AB takes a first step in introducing the rapid test for bladder cancer, UBC® Rapid, in the USA

IDL Biotech has submitted supporting documents to the US FDA (Food and Drug Administration) to be able to obtain future approval of UBC® Rapid, the company's rapid test for bladder cancer.

Abstract shows the value of UBC Rapid

An abstract presented in Tumor Biology (July 2019: 1-74) shows the value of UB® Rapid, for accurate diagnosis and follow-up in bladder cancer.

IDL Biotech

Skip this intro